Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Broadwood Capital Is Still Bullish On BioTime, Inc. (BTX), Further Increases Stake

Neal C. Bradsher, the manager of Broadwood Capital, is still bullish on BioTime, Inc. (NYSEMKT:BTX) and has further increased his fund’s stake in the company. According to a recent Form 4 filing with the Securities and Exchange Commission, Broadwood Capital has added 370,000 shares to its previous position in two transactions, at a price of $2.65 apiece. As a result, Broadwood’s stake surged to approximately 13.8 million BioTime, Inc. (NYSEMKT:BTX) shares, while Bradsher holds an additional 63,000 shares.

BioTime

Jim Simons has also become a fan of BioTime, Inc. (NYSEMKT:BTX) and has initiated a position for his fund during the first quarter of 2014. In its latest 13F filing, Renaissance Technologies has reported ownership of 51,700 shares. Ken Griffin also sees great potential in this company and has increased his fund’s investment by 9% during the same period. Citadel Investment Group holds approximately 13,800 shares as of March 31, 2014. David E Shaw, on the other hand, has chosen to limit his fund’s exposure to BioTime, Inc. (NYSEMKT:BTX) and has cut its stake by 37% to about 49,300 shares.

Disclosure: none.

Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!